Kendrion NV (0G68)
London Exchange · UK · prices in EUR · close of 20 Oct 2026
Key indicators
| Last close | EUR 18.76 |
|---|---|
| 52-week range | 12.07 – 21.60 |
| Return, 1 month / 3 months | −9.3% / −0.7% |
| Return, 1 year / 3 years | +59.5% / +52.8% |
| Trend | Above 200-day, below 50-day |
| RSI (14) | 39 |
| Volatility (1 year) | 28.9% |
| Worst drawdown (1 year) | -14.2% |
| Average daily value traded | 0.03M EUR |
| Dividend yield | 9.1% |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
Kendrion NV is a Dutch industrial company that designs and makes electromagnetic components and systems. Its products include solenoids, electromagnetic brakes and clutches, actuators and control electronics, which are used in automotive systems, industrial machinery and medical equipment. Customers are manufacturers and equipment makers that need reliable motion and switching components, and the company is based in the Netherlands, where it develops and produces these parts for markets in Europe and beyond.
Kendrion NV trades under the code 0G68 on the London Exchange in UK, with its price quoted in euros (EUR). Our dividend records, which start in 2019, show payments in 7 different calendar years. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
Kendrion NV (0G68) trades on the London Exchange in UK. It last closed at EUR 18.76 on 20 October 2026.
Its price-based Market X-Ray is 63 out of 100 (a fair price profile), ranking 1,057 of 3,787 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price rose 59.5% and over the last three months it fell 0.7%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on London Exchange
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 67 · Fair | Mixed trend against its averages. | |
| Above 200-day average | 4.1% | ||
| From 52-week high | -11.9% | ||
| Momentum | 71 · Strong | Rising faster than most stocks on this exchange. | |
| 3-month return | -0.7% | ||
| 6-month return | 10.6% | ||
| 12-month return, skipping the last month | 75.8% | ||
| Stability (higher is calmer) | 77 · Strong | Calmer than most: low volatility and shallow drawdowns. | |
| Volatility, 1 year (lower is calmer) | 28.9% | ||
| Worst drawdown, 1 year (smaller is calmer) | -14.2% | ||
| Liquidity | 20 · Weak | Thinly traded: prices can jump and exits can be hard. | |
| Average daily value traded | 0.03M EUR | ||
| Zero-volume days | 0.0% | ||
| Income | 69 · Fair | Dividend is typical for this exchange. | |
| Dividend yield | 9.1% | ||
| Years with dividends | 5 |
Strengths
- Momentum: Rising faster than most stocks on this exchange.
- Stability (higher is calmer): Calmer than most: low volatility and shallow drawdowns.
Weak spots
- Liquidity: Thinly traded: prices can jump and exits can be hard.
Returns
| 1 week | −1.3% |
|---|---|
| 1 month | −9.3% |
| 3 months | −0.7% |
| 6 months | +10.6% |
| 1 year | +59.5% |
| 3 years | +52.8% |
| 5 years | – |
Signals
| 50-day / 200-day average | 19.66 / 18.03 |
|---|---|
| Golden / death cross (60 days) | None |
| New 52-week high | No |
| Bullish RSI divergence | No |
| Average daily range (ATR) | 0.46 |
Technical summary
Recent dividends
| Ex-dividend date | Amount per share |
|---|---|
| 15 Apr 2026 | EUR 0.7000 |
| 18 Nov 2025 | EUR 1.0000 |
| 16 Apr 2025 | EUR 0.4500 |
| 17 Apr 2024 | EUR 0.4500 |
| 19 Apr 2023 | EUR 0.7200 |
| 13 Apr 2022 | EUR 0.6900 |
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on London Exchange; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.